Cargando…
Intrahepatic cholangiocarcinoma: a dose threshold evaluation in those undergoing transarterial radioembolization
BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is a rare primary hepatic malignancy. One of the treatment strategies which has shown some promise is transarterial radioembolization (TARE). However, data on dose thresholds, arguably the most important aspect of the procedure itself, is still limit...
Autores principales: | Young, Shamar, Torkian, Pooya, Flanagan, Siobhan, D’Souza, Donna, Sanghvi, Tina, Golzarian, Jafar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643573/ https://www.ncbi.nlm.nih.gov/pubmed/37969824 http://dx.doi.org/10.21037/jgo-23-210 |
Ejemplares similares
-
Dynamic Lymphocyte Changes Following Transarterial Radioembolization: Association with Normal Liver Dose and Effect on Overall Survival
por: Young, Shamar, et al.
Publicado: (2022) -
Lung shunt fraction quantification methods in radioembolization: What you need to know
por: Torkian, Pooya, et al.
Publicado: (2022) -
Inflammatory Scores: Comparison and Utility in HCC Patients Undergoing Transarterial Chemoembolization in a North American Cohort
por: Young, Shamar, et al.
Publicado: (2021) -
Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series
por: Vermeulen, Sim, et al.
Publicado: (2023) -
A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma
por: Zhen, Yanhua, et al.
Publicado: (2019)